IL106463A - Arginine L Monomethyl GN Pure Solid Hydrochloride Preparation and Pharmaceutical Preparations Containing Them - Google Patents

Arginine L Monomethyl GN Pure Solid Hydrochloride Preparation and Pharmaceutical Preparations Containing Them

Info

Publication number
IL106463A
IL106463A IL10646393A IL10646393A IL106463A IL 106463 A IL106463 A IL 106463A IL 10646393 A IL10646393 A IL 10646393A IL 10646393 A IL10646393 A IL 10646393A IL 106463 A IL106463 A IL 106463A
Authority
IL
Israel
Prior art keywords
monomethyl
arginine
hydrochloride
arginine hydrochloride
salt
Prior art date
Application number
IL10646393A
Other languages
English (en)
Hebrew (he)
Other versions
IL106463A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL106463A0 publication Critical patent/IL106463A0/xx
Publication of IL106463A publication Critical patent/IL106463A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10646393A 1992-07-24 1993-07-23 Arginine L Monomethyl GN Pure Solid Hydrochloride Preparation and Pharmaceutical Preparations Containing Them IL106463A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215816A GB9215816D0 (en) 1992-07-24 1992-07-24 Arginine derivatives

Publications (2)

Publication Number Publication Date
IL106463A0 IL106463A0 (en) 1993-11-15
IL106463A true IL106463A (en) 1998-08-16

Family

ID=10719277

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10646393A IL106463A (en) 1992-07-24 1993-07-23 Arginine L Monomethyl GN Pure Solid Hydrochloride Preparation and Pharmaceutical Preparations Containing Them

Country Status (24)

Country Link
EP (1) EP0651741B1 (es)
JP (1) JP2878844B2 (es)
KR (1) KR950702528A (es)
CN (1) CN1087624A (es)
AT (1) ATE148451T1 (es)
CA (1) CA2140852A1 (es)
CY (1) CY2085B1 (es)
CZ (1) CZ8095A3 (es)
DE (1) DE69307894T2 (es)
DK (1) DK0651741T3 (es)
ES (1) ES2098051T3 (es)
GB (1) GB9215816D0 (es)
GR (1) GR3022773T3 (es)
HU (1) HU210876A9 (es)
IL (1) IL106463A (es)
MX (1) MX9304466A (es)
NO (1) NO302360B1 (es)
NZ (1) NZ254865A (es)
PL (1) PL307238A1 (es)
RU (1) RU95105249A (es)
SG (1) SG46425A1 (es)
SK (1) SK8295A3 (es)
WO (1) WO1994002453A1 (es)
ZA (1) ZA935348B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
GB9603522D0 (en) * 1996-02-20 1996-04-17 Wellcome Found Chemical process
CA2514575A1 (en) * 2003-01-31 2004-08-12 Teijin Pharma Limited Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
CN1724514B (zh) * 2004-07-19 2010-06-09 上海依福瑞实业有限公司 一种l-高精氨酸盐酸盐的制备方法
WO2007139897A1 (en) * 2006-05-23 2007-12-06 University Of Utah Research Foundation Compositions and methods for the inhibition of endothelial nitric oxide synthase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor

Also Published As

Publication number Publication date
IL106463A0 (en) 1993-11-15
GB9215816D0 (en) 1992-09-09
NO950248D0 (no) 1995-01-23
JP2878844B2 (ja) 1999-04-05
MX9304466A (es) 1994-04-29
SK8295A3 (en) 1995-07-11
RU95105249A (ru) 1996-10-27
DK0651741T3 (da) 1997-05-12
AU669557B2 (en) 1996-06-13
CZ8095A3 (en) 1995-10-18
CN1087624A (zh) 1994-06-08
NO950248L (no) 1995-01-23
KR950702528A (ko) 1995-07-29
DE69307894T2 (de) 1997-06-12
DE69307894D1 (de) 1997-03-13
NO302360B1 (no) 1998-02-23
WO1994002453A1 (en) 1994-02-03
NZ254865A (en) 1996-10-28
ZA935348B (en) 1995-01-23
EP0651741A1 (en) 1995-05-10
PL307238A1 (en) 1995-05-15
GR3022773T3 (en) 1997-06-30
CY2085B1 (en) 1999-03-05
HU210876A9 (en) 1995-09-28
ES2098051T3 (es) 1997-04-16
CA2140852A1 (en) 1994-02-03
SG46425A1 (en) 1998-02-20
EP0651741B1 (en) 1997-01-29
ATE148451T1 (de) 1997-02-15
AU4715793A (en) 1994-02-14
JPH07509239A (ja) 1995-10-12

Similar Documents

Publication Publication Date Title
KR101612642B1 (ko) 테노포비어 알라펜아미드 헤미푸마레이트
US4942166A (en) Crystalline purine compounds
JP3726291B2 (ja) 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
AU739953B2 (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
US7429679B2 (en) Sulphonic acid salt of sibutramine
EP0651741B1 (en) Ng-monomethyl-l-arginine hydrochloride derivatives and process for their preparation
EP0361831B1 (en) Antiviral nucleoside combination
US5856565A (en) Ng-monomethyl-l-argine hydrochloride derivatives and their use in the treatment of septic shock
AU669557C (en) Ng-monomethyl-L-arginine hydrochloride derivatives and their use in the treatment of septic shock
US4914222A (en) Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
AU767334B2 (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
HU206628B (en) Process for producing antiviral, watersoluble, stabile, christalline salts of 2',3'-dideoxyinozine-monohydate, 2,'3'-2'-fluoro-inozine-hemihydrate and pharmaceutical compositions containing them
US3253990A (en) N-methyl glucammonium salicylate and uses therefor
EP0096013B1 (en) Salts of erythromycin showing a combined therapeutic activity, process for their preparation and pharmaceutical formulations containing them
EP0139983B1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
JP4693236B2 (ja) 1−メチル−5−p−トルオイルピロール−2−アセトアミド酢酸グアイアシルエステル(MED15)の新規多形結晶
KR920006420B1 (ko) 광학활성이 있는 류코보린칼슘염의 제조방법
AU769660B2 (en) Carbocyclic nucleoside hemisulfate and its use in treating viral infections
MXPA99010373A (es) Hemisulfato carbociclico nucleosido y su uso en el tratamiento de infecciones virales

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void